- Multiple Podium and Poster Presentations on XIPERE and Gene Therapy Delivery Utilizing SCS Microinjector -
ALPHARETTA, Ga., July 07, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc.(Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS), announced today that several presentations will be delivered at the American Society of Retina Specialists (ASRS) Annual Meeting and the Ophthalmology Innovation Source (OIS) Retina Innovation Summit taking place July 13 16, 2022 in New York, NY.
Together with our partners, we will have a strong presence at the prominent OIS and ASRS meetings next week as we showcase the versatility of our proprietary suprachoroidal delivery platform, said Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer at Clearside Biomedical. Numerous podium and poster presentations will be given on U.S. FDA approved XIPERE, suprachoroidal delivery of gene therapy via our SCS Microinjector, as well as an overview of suprachoroidal delivery across preclinical and clinical studies.
OIS Retina Innovation Summit
ASRS Presentation
Dr. Glenn Yiu, et al. will deliver a podium presentation entitled, Biodistribution of suprachoroidal drug and viral vector delivery across animal models and human trials.
XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use: ASRS Partner Presentations
Clearsides SCS Microinjector: ASRS Partner Presentation
About Clearsides Suprachoroidal Space (SCS) Injection Platform and SCS Microinjector
Clearsides patented, proprietary suprachoroidal space (SCS) injection platform offers unprecedented access to the back of the eye where sight-threatening disease often occurs. Clearsides patented technology is designed to deliver drug to the suprachoroidal space located between the choroid and the outer protective layer of the eye, known as the sclera. The companys unique platform is inherently flexible and intended to work with established and new formulations of medications. Clearsides proprietary SCS Microinjector can be used to inject a wide variety of drug candidates into the SCS. The SCS Microinjector provides targeted delivery to potentially improve efficacy and compartmentalization of medication to reduce or eliminate toxic effects on non-diseased cells. The SCS Microinjector is composed of a syringe and two 30-gauge hollow microneedles of varying lengths, each less than 1.2 millimeters, with a custom-designed hub that optimizes insertion and suprachoroidal administration of drugs.
About XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use
XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use, formerly known as CLS-TA, is a proprietary suspension of the corticosteroid triamcinolone acetonide for administration to the suprachoroidal space for the treatment of macular edema associated with uveitis. Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., has the exclusive license for the commercialization and development of XIPERE in the United States and Canada. Arctic Vision, a specialty ophthalmology company based in China, has the exclusive license for the commercialization and development of XIPERE, which they refer to as Arcatus, in Greater China, South Korea, Australia, New Zealand, India and the ASEAN Countries. XIPERE was approved by the U.S. Food and Drug Administration in October 2021 and is commercially available in the U.S.
Important Safety Information about XIPERE
Indication XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use is a corticosteroid indicated for the treatment of macular edema associated with uveitis.
IMPORTANT SAFETY INFORMATIONPatients should be monitored following injection for elevated intraocular pressure. See Dosage and Administration instructions in full Prescribing Information.
To report SUSPECTED ADVERSE REACTIONS, contact Bausch + Lomb at 1-800-321-4576or FDA at 1-800-FDA-1088 or visit http://www.fda.gov/medwatch.
Please click here for full Prescribing Information.
About Clearside Biomedical
Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS). Clearsides SCS injection platform, utilizing the Companys proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Clearside is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector and strategically partners its SCS injection platform with companies utilizing other ophthalmic therapeutic innovations. Clearsides first product, XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use, is commercially available in the U.S. For more information, please visit http://www.clearsidebio.com.
Cautionary Note Regarding Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as believe, expect, may, plan, potential, will, and similar expressions, and are based on Clearsides current beliefs and expectations. These forward-looking statements include statements regarding the potential benefits of therapies using Clearsides SCS Microinjector. These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements. Risks and uncertainties that may cause actual results to differ materially include uncertainties inherent in the conduct of clinical trials, Clearsides reliance on third parties over which it may not always have full control, uncertainties regarding the COVID-19 pandemic and other risks and uncertainties that are described in Clearsides Annual Report on Form 10-K for the year ended December 31, 2021, filed with the U.S. Securities and Exchange Commission (SEC) on March 11, 2022, and Clearsides other Periodic Reports filed with the SEC. Any forward-looking statements speak only as of the date of this press release and are based on information available to Clearside as of the date of this release, and Clearside assumes no obligation to, and does not intend to, update any forward-looking statements, whether as a result of new information, future events or otherwise.
ALTITUDE is a trademark of REGENXBIO, Inc.
Investor and Media Contacts:
Jenny Kobin Remy Bernarda ir@clearsidebio.com(678) 430-8206
Source: Clearside Biomedical, Inc.
Read the original post:
- Report: Apple acquires French startup behind AI and computer vision technology - 9to5Mac - April 22nd, 2024 [April 22nd, 2024]
- CACI Awarded $1.3 Billion Task Order to Provide Communications and Information Technology Expertise to U.S. ... - Business Wire - April 22nd, 2024 [April 22nd, 2024]
- What is semi-automated offside technology and how does it work? - The Athletic - April 22nd, 2024 [April 22nd, 2024]
- Can technology save us from an ecological apocalypse? - interview - CyberNews.com - April 22nd, 2024 [April 22nd, 2024]
- Does LaLiga have goalline technology? What about other major leagues? - AS USA - April 22nd, 2024 [April 22nd, 2024]
- Driver Assistance Technologies: NHTSA Should Take Action to Enhance Consumer Understanding of Capabilities and ... - Government Accountability Office - March 31st, 2024 [March 31st, 2024]
- OpenAI reveals Voice Engine, but won't yet publicly release the risky AI voice-cloning technology - The Associated Press - March 31st, 2024 [March 31st, 2024]
- Nexalin Technology Full Year 2023 Earnings: US$0.63 loss per share (vs US$0.30 loss in FY 2022) - Yahoo Finance - March 31st, 2024 [March 31st, 2024]
- 'Battle for your brain': What the rise of brain-computer interface technology means for you - WBUR News - March 31st, 2024 [March 31st, 2024]
- Firsthand Technology Value Fund (NASDAQ:SVVC) Research Coverage Started at StockNews.com - Defense World - March 31st, 2024 [March 31st, 2024]
- Suzhou Anjie Technology Full Year 2023 Earnings: Misses Expectations - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- Inside the shadowy global battle to tame the world's most dangerous technology - POLITICO Europe - March 31st, 2024 [March 31st, 2024]
- The Technological Pivot Of History: Power In The Age Of Exponential Innovation Analysis - Eurasia Review - March 31st, 2024 [March 31st, 2024]
- 'Women Behind the Wheel' explores the intersection of gender, culture and cars - NPR - March 31st, 2024 [March 31st, 2024]
- Shanghai Weihong Electronic Technology Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- A Look At The Fair Value Of Powertech Technology Inc. (TWSE:6239) - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- Weaver Network Technology Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- New York City will introduce controversial AI gun detection technology amid subway crime crisis - SiliconANGLE News - March 31st, 2024 [March 31st, 2024]
- Earnings Not Telling The Story For Beijing CTJ Information Technology Co., Ltd. (SZSE:301153) - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- Vontron Technology Full Year 2023 Earnings: EPS: CN0.35 (vs CN0.34 in FY 2022) - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- Huawei Revenue Rises as Technology Giant Commits to Growth - Technology Magazine - March 31st, 2024 [March 31st, 2024]
- Shenzhen Fortune Trend technology Full Year 2023 Earnings: Beats Expectations - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- USPACE Technology Group Limited (HKG:1725) May Have Run Too Fast Too Soon With Recent 28% Price Plummet - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- NYC to test gun-detecting technology in subway system - SILive.com - March 31st, 2024 [March 31st, 2024]
- Cancer Treatment: 3D Printing and Scanning Technology - Surviving Mesothelioma - March 31st, 2024 [March 31st, 2024]
- Does Contel Technology (HKG:1912) Have A Healthy Balance Sheet? - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- Oppo Find X7 series now supports 5G-Advanced technology with up to 10 Gbps downlink speed - The Indian Express - March 31st, 2024 [March 31st, 2024]
- DCPS receives nearly $20k in grants for technology program advancements - The Owensboro Times - March 31st, 2024 [March 31st, 2024]
- Hangzhou Electronic Soul Network Technology Full Year 2023 Earnings: Misses Expectations - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- International Business Digital Technology Full Year 2023 Earnings: CN0.07 loss per share (vs CN0.019 loss in FY ... - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- Analysts Are More Bearish On Guangzhou Tinci Materials Technology Co., Ltd. (SZSE:002709) Than They Used To Be - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- Daheng New Epoch Technology Full Year 2023 Earnings: EPS: CN0.11 (vs CN0.16 in FY 2022) - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- Tesla offers U.S. customers a month's trial of its driver-assist technology - Reuters - March 31st, 2024 [March 31st, 2024]
- Slam Dunk Technology: How AI Is Revolutionizing The Game Of Basketball - Forbes - March 31st, 2024 [March 31st, 2024]
- China Environmental Technology and Bioenergy Holdings Full Year 2023 Earnings: CN0.03 loss per share (vs CN ... - Simply Wall St - March 31st, 2024 [March 31st, 2024]
- Vuma and Huawei team up to launch industry first 50G PON ... - Light Reading - July 15th, 2023 [July 15th, 2023]
- See What Kim Kardashian and Kylie Jenner Look Like With Aging ... - E! NEWS - July 15th, 2023 [July 15th, 2023]
- AFRL conducts swarm technology demonstration > ONE AFRL ... - afrl.af.mil - May 20th, 2023 [May 20th, 2023]
- Shell to use new AI technology in deep sea oil exploration - Reuters - May 20th, 2023 [May 20th, 2023]
- Former Google CEO says AI at 'center' of technology competition between US and China - Fox News - May 20th, 2023 [May 20th, 2023]
- Agriculture and technology combine to drive the industrys growth - Times of India - May 20th, 2023 [May 20th, 2023]
- Technology and the Skills Shortage - Financial Times - May 20th, 2023 [May 20th, 2023]
- New License Agreement Announced for Next-Generation Base ... - BioPharm International - May 20th, 2023 [May 20th, 2023]
- Orion Governance Licenses Technology from GE to Deliver Next Generation Data Governance Solution - Yahoo Finance - May 20th, 2023 [May 20th, 2023]
- World needs to be 'vigilant' as AI technology improves and ... - KTVZ - May 20th, 2023 [May 20th, 2023]
- After Losing Son, Ridgefield Mother Pushes For Technology to Prevent Hot Car Deaths - NBC Connecticut - May 20th, 2023 [May 20th, 2023]
- After last year's fan violence in Queretaro, has Fan ID technology ensured safety for Liga MX fans? - ESPN - ESPN - May 20th, 2023 [May 20th, 2023]
- Bleach: The Soul Reapers' Gigai Technology, Explained - CBR - Comic Book Resources - May 20th, 2023 [May 20th, 2023]
- Cogito Tech - Catalyzing Transformation in Global Healthcare ... - Business Standard - May 20th, 2023 [May 20th, 2023]
- Barriers to Use of Technology in Diabetes Management - Patient Care Online - May 20th, 2023 [May 20th, 2023]
- Blue technology startups presented at the inaugural Gulf Blue ... - The University of Southern Mississippi - May 20th, 2023 [May 20th, 2023]
- CureVac files expanded patent lawsuit against Pfizer/BioNTech over ... - Reuters - May 20th, 2023 [May 20th, 2023]
- Harrison Ford defends use of de-ageing technology in new Indiana Jones film: I know that that is my face - Yahoo News - May 20th, 2023 [May 20th, 2023]
- Sanwo-Olu: Nigeria needs technology to compete with likes of China - Guardian Nigeria - May 20th, 2023 [May 20th, 2023]
- Prejudice in technology, and the necessity of time: Books in brief - Nature.com - May 20th, 2023 [May 20th, 2023]
- New technology uses ordinary sunlight to disinfect drinking water ... - Stanford University News - May 20th, 2023 [May 20th, 2023]
- Incredible AI technology shows what UK cities will look like in 2050 - LADbible - May 20th, 2023 [May 20th, 2023]
- Your Firm and Your Tools - Top Technology Initiatives - CPAPracticeAdvisor.com - May 20th, 2023 [May 20th, 2023]
- Tom Hanks: I could appear in movies after death with AI technology - BBC - May 20th, 2023 [May 20th, 2023]
- Transform your career with Chief Technology Officer online course - Economic Times - May 20th, 2023 [May 20th, 2023]
- e-Learning Jamaica Technology in Education Conference Slated for ... - Government of Jamaica, Jamaica Information Service - May 20th, 2023 [May 20th, 2023]
- Andrew Maynard | What's a Luddite? From Industrial Revolution to ... - TribDem.com - May 20th, 2023 [May 20th, 2023]
- At Yale, Kaloyan Kolev used technology to create and to make ... - Yale News - May 20th, 2023 [May 20th, 2023]
- This technology could alter the entire planet. These groups want every nation to have a say. - MIT Technology Review - April 17th, 2023 [April 17th, 2023]
- The secret lives of snakes and how Georgia College uses technology to study them - 13WMAZ.com - April 8th, 2023 [April 8th, 2023]
- Technology Innovation Institute to host 2nd 'Additive Manufacturing the Future' seminar in Abu Dhabi - Devdiscourse - April 8th, 2023 [April 8th, 2023]
- Can Array Technologies Inc (ARRY) Stock Rise to the Top of Technology Sector Thursday? - InvestorsObserver - March 31st, 2023 [March 31st, 2023]
- Here's Why We Think Pfeiffer Vacuum Technology (ETR:PFV) Might Deserve Your Attention Today - Simply Wall St - February 18th, 2023 [February 18th, 2023]
- Will WM Technology Inc (MAPS) Stay at the Top of the Technology Sector? - InvestorsObserver - February 18th, 2023 [February 18th, 2023]
- Ways in which technology can enhance the abilities of law enforcement agents to assist the community - Times of India - February 7th, 2023 [February 7th, 2023]
- Meet The Titans: Google And OpenView (Microsoft) Faceoff On Chat Technology Innovation - Forbes - February 5th, 2023 [February 5th, 2023]
- MACOM Technology Solutions Holdings, Inc.'s (NASDAQ:MTSI) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - Simply Wall St - February 5th, 2023 [February 5th, 2023]
- WVU Dept. of Ophthalmology acquires state-of-the-art technology for simulation lab - WV News - February 5th, 2023 [February 5th, 2023]
- Executive Vice President of Technology & Operations Alok Sethi Just Sold A Bunch Of Shares In Franklin Resources, Inc. (NYSE:BEN) - Simply Wall St - February 5th, 2023 [February 5th, 2023]
- Is Now The Time To Put Amkor Technology (NASDAQ:AMKR) On Your Watchlist? - Simply Wall St - January 27th, 2023 [January 27th, 2023]
- There Are Reasons To Feel Uneasy About New Oriental Education & Technology Group's (NYSE:EDU) Returns On Capital - Simply Wall St - January 27th, 2023 [January 27th, 2023]
- Technology has set us on a path toward one of two dystopian scenariosbut its not too late to save democracy - Fortune - January 17th, 2023 [January 17th, 2023]
- IonQ Acquires Entangled Networks And Locks In Quantum Networking Technology Critical To Its Future Success - Forbes - January 10th, 2023 [January 10th, 2023]
- Industrialization 3.0 - How Technology, Wall Street, And The Government Can Help The US Win In A World Of Re-Industrialization - Forbes - January 10th, 2023 [January 10th, 2023]
- Connect with aspirational India through technology and work in interest of world: Anurag Thakur to NRIs - Economic Times - January 8th, 2023 [January 8th, 2023]